Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $44.45 and last traded at $44.45, with a volume of 0 shares traded. The stock had previously closed at $44.45.
Basilea Pharmaceutica Stock Performance
The firm has a 50-day moving average of $40.87 and a 200-day moving average of $41.61.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Read More
- Five stocks we like better than Basilea Pharmaceutica
- The How And Why of Investing in Oil Stocks
- Silicon Motion Proves That AI in Motion Stays in Motion
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Undervalued UnitedHealth Group Won’t Be For Long
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
